FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
XENLETA
lefamulin acetate
Peak
Zai Lab
INTRAVENOUS · SOLUTION
2019
NDA0/100
XENLETA
lefamulin acetate
Peak
Zai Lab
ORAL · TABLET
2019
NDA0/100
XENOVIEW
xenon xe 129 hyperpolarized
Peak
Polarean Imaging
INHALATION · GAS
2022
NDA0/100
XEPI
ozenoxacin
Peak
TOPICAL · CREAM
2017
SMNDA0/100
XERAVA
eravacycline
Peak
RAPHAS
INTRAVENOUS · POWDER
2018
SMNDA0/100
XERMELO
telotristat ethyl
Peak
TerSera Therapeutics
ORAL · TABLET
2017
NDA0/100
XHANCE
fluticasone propionate
Peak
Paratek Pharmaceuticals
NASAL · SPRAY, METERED
2017
NDA0/100
XIGDUO XR
dapagliflozin and metformin hydrochloride
Peak
AstraZeneca
ORAL · TABLET, EXTENDED RELEASE
end stage kidney diseasecardiovascular death+5
2014
NDA0/100
XIIDRA
lifitegrast
Peak
Bausch + Lomb
OPHTHALMIC · SOLUTION/DROPS
2016
NDA0/100
XIPERE
triamcinolone acetonide
Peak
Bausch + Lomb
INJECTION · SUSPENSION
2021
NDA0/100
XOFLUZA
baloxavir marboxil
Peak
Roche
ORAL · FOR SUSPENSION
acute uncomplicated influenza in patients 5 years of ageolder+1
2020
NDA0/100
XOFLUZA
baloxavir marboxil
Peak
Roche
ORAL · TABLET
acute uncomplicated influenza in patients 5 years of ageolder+1
2018
NDA0/100
XOSPATA
gilteritinib
Peak
Astellas
ORAL · TABLET
refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation
2018
SMNDA0/100
XPOVIO
selinexor
Peak
Mthera Pharma
ORAL · TABLET
2019
NDA0/100
XTAMPZA ER
oxycodone
Peak
ORAL · CAPSULE, EXTENDED RELEASE
2016
NDA0/100
XTANDI
enzalutamide
Peak
Astellas
ORAL · TABLET
2020
NDA0/100
XTANDI
enzalutamide
Peak
Astellas
ORAL · CAPSULE
2012
NDA0/100
XTORO
finafloxacin
Peak
OTIC · SUSPENSION/DROPS
2014
SMNDA0/100
XYOSTED (AUTOINJECTOR)
testosterone enanthate
Peak
Antares Therapeutics
SUBCUTANEOUS · SOLUTION
2018
NDA0/100
XYREM
sodium oxybate
Peak
Jazz Pharmaceuticals
ORAL · SOLUTION
cataplexyexcessive daytime sleepiness (EDS) in patients 7 years of age+1
2002
NDA0/100
XYWAV
calcium, magnesium, potassium, and sodium oxybates
Peak
Jazz Pharmaceuticals
ORAL · SOLUTION
2020
NDA0/100
YONSA
abiraterone acetate
Peak
Fosun Pharma
ORAL · TABLET
2018
NDA0/100
YOSPRALA
aspirin; omeprazole
Peak
ORAL · TABLET, DELAYED RELEASE
2016
SMNDA0/100
YUPELRI
revefenacin
Peak
Viatris (2)
INHALATION · SOLUTION
2018
NDA0/100